Literature DB >> 6211306

Disordered immunoregulatory functions in patients with chronic active hepatitis.

A Nonomura, M Tanino, H Kurumaya, G Ohta, Y Kato, K Kobayashi.   

Abstract

Peripheral T lymphocytes from patients with chronic active hepatitis (CAH) showed a significantly decreased suppressor cell (or increased helper cell) effect on differentiation of allogenic B cells to Ig-producing cells (Ig-PC). Spontaneous helper cell activity as measured after irradiation of T cells appeared normal, while Concanavalin A (Con A)-induced suppressor cell activity was significantly reduced. Some patients of chronic persistent hepatitis (CPH) also showed mild depression of Con A-induced suppressor cell activity. Poor suppressor cell activity in CAH was much more often seen in HBsAg negative, autoantibody positive patients than in HBsAg positive autoantibody negative ones. Autologous mixed lymphocyte reaction (AMLR) was significantly decreased in patients with CAH. Also, a serum factor(s) that decreased Con A-induced suppressor cell function of healthy subjects could be demonstrated in some patients with CAH and CPH. Our results suggest that altered immune responses observed in CAH may be due to defective suppressor cell function, partly attributable to serum factor(s).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211306      PMCID: PMC1536421     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

Review 1.  T cell control of antibody production.

Authors:  R K Gershon
Journal:  Contemp Top Immunobiol       Date:  1974

2.  T and B lymphocytes in acute and chronic hepatitis.

Authors:  R J DeHoratius; R G Strickland; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1974-04

3.  Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis.

Authors:  B H Toh; I C Roberts-Thomson; J D Mathews; S Whittingham; I R Mackay
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

4.  [Differential reaction of lymphocytes to phytohemagglutinin (PHA) in liver diseases].

Authors:  R Rössler; K Havemann; W Dölle
Journal:  Klin Wochenschr       Date:  1969-08-01

5.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  [Cellular immune reactions towards homologous liver-specific antigens (HLP) in chronic inflammatory liver diseases (author's transl)].

Authors:  K H von Meyer zum Büschenfelde; J Knolle; J Berger
Journal:  Klin Wochenschr       Date:  1974-03-01

7.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

8.  Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction.

Authors:  N L Gerber; J A Hardin; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

9.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  10 in total

1.  Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression.

Authors:  A W Lohse; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 2.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

4.  Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-08

5.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

6.  IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

7.  Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.

Authors:  G Lemm; K Salzer; H Warnatz
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-04

9.  In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.

Authors:  K T Nouri-Aria; G J Alexander; B Portmann; D Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Immunological studies in patients with HBsAg-positive chronic active hepatitis--spontaneous lymphocyte transformation and natural killer cell activity.

Authors:  J Y Koo; B C Park; J M Chung
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.